The "E-Pharma Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The e-pharma ...

Amgen has been a biotechnology pioneer since 1980. The global pharma company's ongoing mission is "to serve patients" and one way to complete this mission is by keeping up-to-date with the latest ...

Global private equity ... stake in Hyderabad-based Gland Pharma Ltd from China’s Shanghai Fosun Pharmaceutical Co. Ltd in a deal expected to value the company at nearly $3 billion, three people ...

Managing for global impact continues to be a challenge for many pharma companies, which have traditional structures suited to a ‘pre-digital’ environment. This is an issue that global ...

To join the ESSA Pharma Inc. class action, go to https://rosenlegal.com/submit-form/?case_id=34133 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee), a leading healthcare company in Korea, announced the ...

the Company will benefit from the full support of Bain Capital’s global resources and our healthcare team’s extensive experience driving value creation across the healthcare value chain. We look ...

New Delhi [India], February 11 (ANI): India’s pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 per cent by 2030, according to a ...

Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex. One by one, the defendants reached settlements with Jazz, with Apotex ...

New Delhi: Tamarind Global, a homegrown destination management company, has launched a brand-new logo as part of its transformative brand revamp. More than just a visual update, the new logo ...

India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 per cent by 2030, according to a report by Bain & Company. The Indian pharma ...